Admission Date:  [**2115-4-23**]              Discharge Date:   [**2115-5-13**]  Date of Birth:  [**2039-10-28**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1481**] Chief Complaint: Esophageal cancer  Major Surgical or Invasive Procedure: Minimally invasive esophagogastrectomy with abdominal conversion, exploratory laparoscopy, feeding jejunostomy, splenectomy.
History of Present Illness: Mr. [**Known lastname **] is a 75-year-old man diagnosed with T3 N1 adenocarcinoma of the distal esophagus treated with neoadjuvant chemoradiation who presents for elective esophagectomy.
Paraesophageal lymph node (S):  One lymph node, no carcinoma seen.
Additional Pathologic Findings:  Intestinal metaplasia, dysplasia.
Clinical:  Esophageal cancer - status post chemotherapy.
There is a stapled proximal resection margin measuring 2.5 cm in length and a stapled distal resection margin measuring 8.5 cm.
The total length of esophagus measures 24 cm.
The specimen is represented as follows: A = stapled distal resection, B = stapled proximal resection margin of esophagus, C = distal resection margin, D-F = tumor, G = GE junction, H = stomach, I = Z-line, J = esophagus, K = area near second staple line near proximal resection margin, L = area of largest lymph node, M-Q = individual lymph nodes.
Part 2 is additionally labeled "subcarinal lymph node" and consists of a 0.9 x 0.8 x 0.3 cm lymph node that is bisected and entirely submitted in R.  Part 3 is additionally labeled "para-esophageal lymph nodes and consists of a lymph node and associated fat measuring 1.2 x 0.7 x 0.4 cm.
There is a stapled resection margin at the hilum measuring 6 cm.
Cardiology Report ECHO Study Date of [**2115-5-3**] MEASUREMENTS: Left Atrium - Long Axis Dimension: *4.2 cm (nl <= 4.0 cm) Left Ventricle - Septal Wall Thickness: *1.2 cm (nl 0.6 - 1.1 cm) Left Ventricle - Inferolateral Thickness: *1.2 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: 5.5 cm (nl <= 5.6 cm) Left Ventricle - Systolic Dimension: 3.7 cm Left Ventricle - Fractional Shortening: 0.33 (nl >= 0.29) Left Ventricle - Ejection Fraction: >= 65% (nl >=55%) Aorta - Valve Level: 3.6 cm (nl <= 3.6 cm) Aorta - Ascending: 3.2 cm (nl <= 3.4 cm) Aortic Valve - Peak Velocity: 1.3 m/sec (nl <= 2.0 m/sec) Mitral Valve - E Wave: 0.6 m/sec Mitral Valve - A Wave: 0.9 m/sec Mitral Valve - E/A Ratio: 0.67 Mitral Valve - E Wave Deceleration Time: 151 msec  INTERPRETATION: Findings: LEFT ATRIUM: Mild LA enlargement.
Brief Hospital Course: The patient was admitted to the Crimson Surgery service and underwent minimally invasive esophagogastrectomy converted to open with splenectomy and feeding jejunostomy on [**2115-4-23**] by Drs.
He remained intubated postoperatively and was transferred to the CSRU in stable condition.
The patient was resuscitated with crystalloid and packed red blood cells POD 1 due to low urine output.
He remained sedated and intubated.
POD 2, trophic tube feedings were initiated.
Ativan and Haldol had to be administered a couple of times for agitation, confusion, and tube/IV pulling.
He was maintained on a heparin drip for his paroxysmal afib and received nutrition via tube feeding.
His INR was therapeutic on warfarin (given for paroxysmal afib, pt currently in sinus rhythm, goal INR 2.0) and the heparin drip was discontinued.
On POD 20 he was dishcarged to a rehabilitation center in fair condition with specific instructions for post-hospital care and follow-up.
Medications on Admission: [**First Name9 (NamePattern2) **] [**Last Name (un) **] lipitor ASA nexium MVI vitamin E seaweed  Discharge Medications: 1.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Oxycodone-Acetaminophen 5-325 mg/5 mL Solution Sig: 5-10 MLs PO Q4-6H (every 4 to 6 hours) as needed.
Albuterol Sulfate 0.083 % Solution Sig: [**2-11**]  Inhalation Q4H (every 4 hours) as needed.
Ipratropium Bromide 0.02 % Solution Sig: [**2-11**]  Inhalation Q4H (every 4 hours).
Lorazepam 0.5 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed.
Lansoprazole 30 mg Susp,Delayed Release for Recon Sig: One (1)  PO DAILY (Daily).
Amiodarone 200 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
8. insulin Insulin SC  (per Insulin Flowsheet)       Sliding Scale 9.
Metoprolol Tartrate 25 mg Tablet Sig: 1.5 Tablets PO TID (3 times a day).
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed.
Tamsulosin 0.4 mg Capsule, Sust.
Warfarin 1 mg Tablet Sig: One (1) Tablet PO at bedtime: dose varies depending on INR.
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 325 mg Tablet, Delayed Release (E.C.)
Please take medications as prescribed and read warning labels carefully.
Please remember to follow up your Coumadin dosing with your primary care provider.
